Enhancement of Immune Responses by Co-delivery of CCL19/MIP-3beta Chemokine Plasmid With HCV Core DNA/Protein Immunization-Reference-Cited by-同舟云学术

Enhancement of Immune Responses by Co-delivery of CCL19/MIP-3beta Chemokine Plasmid With HCV Core DNA/Protein Immunization

Published:2014-03-01 Issue:3 Volume:14 Page:
ISSN:1735-143X
Container-title:Hepatitis Monthly
language:
Short-container-title:Hepat Mon

Author:

Hartoonian Christine,Sepehrizadeh Zargham,Tabatabai Yazdi Mojtaba,Jang Yong Suk,Langroudi Lida,Amir Kalvanagh Parisa,Negahdari Babak,Karami Ali,Ebtekar Massoumeh,Azadmanesh Kayhan

Publisher

Briefland

Subject

Infectious Diseases,Hepatology

Reference31 articles.

1. Hepatitis C virus: virology and life cycle

2. The hepatitis C virus persistence: how to evade the immune system?

3. Economic evaluation of direct-acting antiviral therapy in chronic hepatitis C

4. Triple therapy with boceprevir or telaprevir for treatment naïve HCV patients

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring T-Cell Immunity to Hepatitis C Virus: Insights from Different Vaccine and Antigen Presentation Strategies;Vaccines;2024-08-06

2. Hepatitis C virus DNA vaccines: a systematic review;Virology Journal;2021-12

3. CCR7 in Blood Cancers – Review of Its Pathophysiological Roles and the Potential as a Therapeutic Target;Frontiers in Oncology;2021-10-29

4. CCL19 and CCL28 Assist Herpes Simplex Virus 2 Glycoprotein D To Induce Protective Systemic Immunity against Genital Viral Challenge;mSphere;2021-04-28

5. Duck hepatitis A virus 1 has lymphoid tissue tropism altering the organic immune responses of mature ducks;Transboundary and Emerging Diseases;2021-01-07